Soleno Therapeutics (SLNO) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.95
-0.72
-0.5
-0.27

Details

Expected EPS
-0.367143
Actual EPS
-0.59
Surprise EPS
-0.22
Surprise Percent
+60.7%

Description

Soleno Therapeutics (SLNO) has reported earnings of -0.59 per share for Q2 2024.

0 Comments

Share your thoughts